{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:52:41Z","timestamp":1791975161608,"version":"4.4.0"},"reference-count":95,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1097\/mop.0b013e328343cd16","type":"journal-article","created":{"date-parts":[[2011,2,4]],"date-time":"2011-02-04T06:30:37Z","timestamp":1296801037000},"page":"208-214","source":"Crossref","is-referenced-by-count":11,"title":["Accidental and iatrogenic causes of acute kidney injury"],"prefix":"10.1097","volume":"23","author":[{"given":"Katherine","family":"Twombley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyothsna","family":"Gattineni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210206","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.ajkd.2004.09.028","article-title":"Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001","volume":"45","author":"Hui-Stickle","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R2-14-20210206","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/sj.ki.5000032","article-title":"3\u20135 year longitudinal follow-up of pediatric patients after acute renal failure","volume":"69","author":"Askenazi","year":"2006","journal-title":"Kidney Int"},{"key":"R3-14-20210206","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMra054415","article-title":"Assessing kidney function: measured and estimated glomerular filtration rate","volume":"354","author":"Stevens","year":"2006","journal-title":"N Engl J Med"},{"key":"R4-14-20210206","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s004670050565","article-title":"Ketorolac-induced irreversible renal failure in sickle cell disease: a case report","volume":"13","author":"Simckes","year":"1999","journal-title":"Pediatr Nephrol"},{"key":"R5-14-20210206","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1054-139X(98)00036-6","article-title":"Nonsteroidal anti-inflammatory drug use in adolescence","volume":"23","author":"Nakahura","year":"1998","journal-title":"J Adolesc Health"},{"key":"R6-14-20210206","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s004310100729","article-title":"Severe reversible renal failure due to naproxen-associated acute interstitial nephritis","volume":"160","author":"Becker-Cohen","year":"2001","journal-title":"Eur J Pediatr"},{"key":"R7-14-20210206","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1542\/peds.85.5.844","article-title":"Nephrotic syndrome associated with nonsteroidal anti-inflammatory drug use in two children","volume":"85","author":"Robinson","year":"1990","journal-title":"Pediatrics"},{"key":"R8-14-20210206","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1542\/peds.80.6.904","article-title":"Naproxen-associated renal failure in a child with arthritis and inflammatory bowel disease","volume":"80","author":"Laxer","year":"1987","journal-title":"Pediatrics"},{"key":"R9-14-20210206","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s00467-003-1167-4","article-title":"Renal papillary necrosis induced by naproxen","volume":"18","author":"Kovacevic","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"R10-14-20210206","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00467-005-1966-x","article-title":"Acute renal failure, associated with nonsteroidal anti-inflammatory drugs in healthy children","volume":"20","author":"Krause","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"R11-14-20210206","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s00467-008-0835-9","article-title":"Oral-ibuprofen-induced acute renal failure in a preterm infant","volume":"23","author":"Erdeve","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"R12-14-20210206","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S0272-6386(96)90570-3","article-title":"The renal effects of nonsteroidal anti-inflammatory drugs: summary and recommendations","volume":"28","author":"Bennett","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"R13-14-20210206","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1053\/sarh.2002.37216","article-title":"Anti-inflammatory agents and renal function","volume":"32","author":"Brater","year":"2002","journal-title":"Semin Arthritis Rheum"},{"key":"R14-14-20210206","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/ki.1993.293","article-title":"Renal complications of nonsteroidal anti-inflammatory drugs","volume":"44","author":"Schlondorff","year":"1993","journal-title":"Kidney Int"},{"key":"R15-14-20210206","first-page":"F1","article-title":"Nephrotoxic acute renal failure due to common drugs","volume":"241","author":"Porter","year":"1981","journal-title":"Am J Physiol"},{"issue":"Suppl","key":"R16-14-20210206","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1093\/infdis\/124.Supplement_1.S70","article-title":"Pharmacokinetics of gentamicin: distribution and plasma and renal clearance","volume":"124","author":"Gyselynck","year":"1971","journal-title":"J Infect Dis"},{"key":"R17-14-20210206","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1128\/AAC.9.6.925","article-title":"Concentrations of gentamicin and amikacin in human kidneys","volume":"9","author":"Edwards","year":"1976","journal-title":"Antimicrob Agents Chemother"},{"key":"R18-14-20210206","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/infdis\/130.6.656","article-title":"Renal parenchymal accumulation of aminoglycoside antibiotics in rats","volume":"130","author":"Luft","year":"1974","journal-title":"J Infect Dis"},{"key":"R19-14-20210206","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/ki.1984.69","article-title":"Early effects of gentamicin, tobramycin, and amikacin on the human kidney","volume":"25","author":"De Broe","year":"1984","journal-title":"Kidney Int"},{"key":"R20-14-20210206","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/ki.1980.176","article-title":"Gentamicin-induced nephrotoxicity: a cell biology approach","volume":"18","author":"Morin","year":"1980","journal-title":"Kidney Int"},{"key":"R21-14-20210206","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/ki.1981.19","article-title":"Pathophysiology of altered glomerular function in aminoglycoside-treated rats","volume":"19","author":"Schor","year":"1981","journal-title":"Kidney Int"},{"key":"R22-14-20210206","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0022-3565(25)32958-7","article-title":"The renin-angiotensin system in aminoglycoside-induced acute renal failure","volume":"220","author":"Luft","year":"1982","journal-title":"J Pharmacol Exp Ther"},{"key":"R23-14-20210206","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ki.1983.162","article-title":"Role of tubular obstruction in acute renal failure due to gentamicin","volume":"24","author":"Neugarten","year":"1983","journal-title":"Kidney Int"},{"key":"R24-14-20210206","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ki.1983.189","article-title":"Cortical and papillary absorptive defects in gentamicin nephrotoxicity","volume":"24","author":"Safirstein","year":"1983","journal-title":"Kidney Int"},{"key":"R25-14-20210206","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/ki.1995.190","article-title":"Gentamicin activates rat mesangial cells. A role for platelet activating factor","volume":"47","author":"Rodriguez-Barbero","year":"1995","journal-title":"Kidney Int"},{"key":"R26-14-20210206","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1128\/AAC.43.5.1003","article-title":"Aminoglycosides: nephrotoxicity","volume":"43","author":"Mingeot-Leclercq","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"R27-14-20210206","first-page":"273","article-title":"Studies on the mechanism of nonoliguric experimental acute renal failure","volume":"54","author":"Appel","year":"1981","journal-title":"Yale J Biol Med"},{"key":"R28-14-20210206","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s004670050378","article-title":"Gentamicin-induced Bartter-like syndrome","volume":"11","author":"Landau","year":"1997","journal-title":"Pediatr Nephrol"},{"key":"R29-14-20210206","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00467-003-1381-0","article-title":"Acute effects of gentamicin on urinary electrolyte excretion in neonates","volume":"19","author":"Giapros","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"R30-14-20210206","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/000992280003900904","article-title":"Syndrome of hypokalemic metabolic alkalosis and hypomagnesemia associated with gentamicin therapy: case reports","volume":"39","author":"Shetty","year":"2000","journal-title":"Clin Pediatr (Phila)"},{"key":"R31-14-20210206","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000092061","article-title":"Antibiotics-induced acute interstitial nephritis in 6 children","volume":"76","author":"Papachristou","year":"2006","journal-title":"Urol Int"},{"key":"R32-14-20210206","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00467-008-1036-2","article-title":"Cystic fibrosis, aminoglycoside treatment and acute renal failure: the not so gentle micin","volume":"24","author":"Bockenhauer","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"R33-14-20210206","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7326\/0003-4819-100-3-352","article-title":"Risk factors for nephrotoxicity in patients treated with aminoglycosides","volume":"100","author":"Moore","year":"1984","journal-title":"Ann Intern Med"},{"key":"R34-14-20210206","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/infdis\/153.6.1062","article-title":"A model for predicting nephrotoxicity in patients treated with aminoglycosides","volume":"153","author":"Sawyers","year":"1986","journal-title":"J Infect Dis"},{"key":"R35-14-20210206","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/qjmed\/hcp143","article-title":"Gentamicin-associated acute kidney injury","volume":"102","author":"Selby","year":"2009","journal-title":"QJM"},{"key":"R36-14-20210206","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1542\/peds.114.1.e111","article-title":"Extended-interval aminoglycoside administration for children: a meta-analysis","volume":"114","author":"Contopoulos-Ioannidis","year":"2004","journal-title":"Pediatrics"},{"key":"R37-14-20210206","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1592\/phco.29.11.1275","article-title":"Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"29","author":"Rybak","year":"2009","journal-title":"Pharmacotherapy"},{"key":"R38-14-20210206","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1128\/AAC.14.4.634","article-title":"Safety of oral vancomycin in functionally anephric patients","volume":"14","author":"Bryan","year":"1978","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl","key":"R39-14-20210206","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.1093\/clinids\/3.Supplement_2.S230","article-title":"Pharmacokinetics of vancomycin in normal subjects and in patients with reduced renal function","volume":"3","author":"Moellering","year":"1981","journal-title":"Rev Infect Dis"},{"key":"R40-14-20210206","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1128\/AAC.25.4.433","article-title":"Pharmacokinetics of vancomycin in patients with various degrees of renal function","volume":"25","author":"Matzke","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"R41-14-20210206","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/00003246-200206000-00013","article-title":"Aminoglycoside and glycopeptide renal toxicity in intensive care patients studied by proton magnetic resonance spectroscopy of urine","volume":"30","author":"Le","year":"2002","journal-title":"Crit Care Med"},{"key":"R42-14-20210206","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1440-1681.2007.04695.x","article-title":"Novel evidence suggesting an antioxidant property for erythropoietin on vancomycin-induced nephrotoxicity in a rat model","volume":"34","author":"Cetin","year":"2007","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R43-14-20210206","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.tox.2005.07.009","article-title":"In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine","volume":"215","author":"Oktem","year":"2005","journal-title":"Toxicology"},{"key":"R44-14-20210206","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1742-7843.2005.pto_153.x","article-title":"Protective effects of different antioxidants and amrinone on vancomycin-induced nephrotoxicity","volume":"97","author":"Celik","year":"2005","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"R45-14-20210206","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2133\/dmpk.19.68","article-title":"Protective effect of inactive ingredients against nephrotoxicity of vancomycin hydrochloride in rats","volume":"19","author":"Hodoshima","year":"2004","journal-title":"Drug Metab Pharmacokinet"},{"key":"R46-14-20210206","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.tiv.2004.03.013","article-title":"Proliferative responses observed following vancomycin treatment in renal proximal tubule epithelial cells","volume":"18","author":"King","year":"2004","journal-title":"Toxicol In Vitro"},{"key":"R47-14-20210206","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1086\/600884","article-title":"Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients","volume":"49","author":"Lodise","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R48-14-20210206","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/ki.2010.35","article-title":"Recent changes in vancomycin use in renal failure","volume":"77","author":"Vandecasteele","year":"2010","journal-title":"Kidney Int"},{"key":"R49-14-20210206","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","article-title":"High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity","volume":"166","author":"Hidayat","year":"2006","journal-title":"Arch Intern Med"},{"key":"R50-14-20210206","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/INF.0b013e3181906e40","article-title":"Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate","volume":"28","author":"Frymoyer","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R51-14-20210206","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.clinthera.2010.03.005","article-title":"Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: a Monte Carlo simulation","volume":"32","author":"Frymoyer","year":"2010","journal-title":"Clin Ther"},{"issue":"Suppl 1","key":"R52-14-20210206","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/491709","article-title":"Vancomycin: a history","volume":"42","author":"Levine","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"R53-14-20210206","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1086\/491708","article-title":"Vancomycin: a 50-year reassessment","volume":"42","author":"Moellering","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R54-14-20210206","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1128\/AAC.23.1.138","article-title":"Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981","volume":"23","author":"Farber","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"key":"R55-14-20210206","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/jac\/dkn080","article-title":"Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy","volume":"62","author":"Ingram","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"R56-14-20210206","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.clinthera.2007.06.014","article-title":"A retrospective analysis of possible renal toxicity associated with vancomycin in patients with healthcare-associated methicillin-resistant Staphylococcus aureus pneumonia","volume":"29","author":"Jeffres","year":"2007","journal-title":"Clin Ther"},{"key":"R57-14-20210206","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1128\/AAC.01602-07","article-title":"Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R58-14-20210206","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1080\/02841850801995413","article-title":"Contrast-induced nephropathy: the wheel has turned 360 degrees","volume":"49","author":"Thomsen","year":"2008","journal-title":"Acta Radiol"},{"key":"R59-14-20210206","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00261-005-0380-y","article-title":"ESUR guidelines on contrast media","volume":"31","author":"Thomsen","year":"2006","journal-title":"Abdom Imaging"},{"key":"R60-14-20210206","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1523-1755.2005.00377.x","article-title":"Pathophysiology of contrast medium-induced nephropathy","volume":"68","author":"Persson","year":"2005","journal-title":"Kidney Int"},{"key":"R61-14-20210206","doi-asserted-by":"crossref","first-page":"322","DOI":"10.5414\/CNP66322","article-title":"Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients","volume":"66","author":"Feldkamp","year":"2006","journal-title":"Clin Nephrol"},{"key":"R62-14-20210206","doi-asserted-by":"crossref","first-page":"27K","DOI":"10.1016\/j.amjcard.2006.01.022","article-title":"Risk prediction of contrast-induced nephropathy","volume":"98","author":"McCullough","year":"2006","journal-title":"Am J Cardiol"},{"key":"R63-14-20210206","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ccd.21902","article-title":"Contrast administration in pediatric cardiac catheterization: dose and adverse events","volume":"73","author":"Senthilnathan","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"R64-14-20210206","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1056\/NEJMcp050801","article-title":"Clinical practice. Preventing nephropathy induced by contrast medium","volume":"354","author":"Barrett","year":"2006","journal-title":"N Engl J Med"},{"key":"R65-14-20210206","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00000441-200306000-00006","article-title":"Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicity","volume":"325","author":"Perazella","year":"2003","journal-title":"Am J Med Sci"},{"key":"R66-14-20210206","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1515\/CCLM.2010.151","article-title":"Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features","volume":"48","author":"Cervellin","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"R67-14-20210206","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1097\/CCM.0b013e318168e375","article-title":"An overview of drug-induced acute kidney injury","volume":"36","author":"Pannu","year":"2008","journal-title":"Crit Care Med"},{"key":"R68-14-20210206","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3949\/ccjm.69.4.289","article-title":"How to prevent, recognize, and treat drug-induced nephrotoxicity.","volume":"69","author":"Guo","year":"2002","journal-title":"Cleve Clin J Med"},{"key":"R69-14-20210206","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2215\/CJN.02050309","article-title":"Renal vulnerability to drug toxicity","volume":"4","author":"Perazella","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R70-14-20210206","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1053\/j.ackd.2010.03.011","article-title":"Chronic kidney disease associated with environmental toxins and exposures","volume":"17","author":"Soderland","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"R71-14-20210206","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/01.ccx.0000184300.68383.95","article-title":"Drug-induced acute kidney injury","volume":"11","author":"Schetz","year":"2005","journal-title":"Curr Opin Crit Care"},{"key":"R72-14-20210206","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nrneph.2010.71","article-title":"Drug-induced acute interstitial nephritis","volume":"6","author":"Perazella","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"R73-14-20210206","first-page":"743","article-title":"Drug-induced nephrotoxicity","volume":"78","author":"Naughton","year":"2008","journal-title":"Am Fam Physician"},{"key":"R74-14-20210206","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2215\/CJN.06011108","article-title":"Current status of gadolinium toxicity in patients with kidney disease","volume":"4","author":"Perazella","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R75-14-20210206","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(00)02694-5","article-title":"Scleromyxoedema-like cutaneous diseases in renal-dialysis patients","volume":"356","author":"Cowper","year":"2000","journal-title":"Lancet"},{"key":"R76-14-20210206","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00467-003-1380-1","article-title":"Nephrogenic fibrosing dermopathy in pediatric patients","volume":"19","author":"Jain","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"R77-14-20210206","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5414\/CNP69161","article-title":"Clinical manifestation of gadodiamide-related nephrogenic systemic fibrosis","volume":"69","author":"Marckmann","year":"2008","journal-title":"Clin Nephrol"},{"key":"R78-14-20210206","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.rcl.2009.05.002","article-title":"How to avoid nephrogenic systemic fibrosis: current guidelines in Europe and the United States.","volume":"47","author":"Thomsen","year":"2009","journal-title":"Radiol Clin North Am"},{"key":"R79-14-20210206","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1259\/bjr\/17689538","article-title":"Nephrogenic systemic fibrosis: risk factors suggested from Japanese published cases","volume":"83","author":"Tsushima","year":"2010","journal-title":"Br J Radiol"},{"key":"R80-14-20210206","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/BF01095963","article-title":"Acyclovir-induced renal failure: course and risk factors","volume":"5","author":"Bianchetti","year":"1991","journal-title":"Pediatr Nephrol"},{"key":"R81-14-20210206","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/BF02254206","article-title":"Acute renal failure in a child associated with acyclovir","volume":"9","author":"Vachvanichsanong","year":"1995","journal-title":"Pediatr Nephrol"},{"key":"R82-14-20210206","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2165\/00148581-200810020-00008","article-title":"Determinants of aciclovir-induced nephrotoxicity in children","volume":"10","author":"Schreiber","year":"2008","journal-title":"Paediatr Drugs"},{"key":"R83-14-20210206","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1053\/j.ajkd.2005.02.010","article-title":"Antiviral drug-induced nephrotoxicity","volume":"45","author":"Izzedine","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R84-14-20210206","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0002-9343(99)00041-8","article-title":"Crystal-induced acute renal failure","volume":"106","author":"Perazella","year":"1999","journal-title":"Am J Med"},{"key":"R85-14-20210206","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/MEJ.0b013e3282f08aa4","article-title":"Complications of heroin abuse","volume":"15","author":"O'Connor","year":"2008","journal-title":"Eur J Emerg Med"},{"key":"R86-14-20210206","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0033-3182(10)70711-8","article-title":"Rhabdomyolysis after LSD ingestion","volume":"51","author":"Berrens","year":"2010","journal-title":"Psychosomatics"},{"key":"R87-14-20210206","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/ndt\/15.3.299","article-title":"Cocaine use and kidney damage","volume":"15","author":"van der Woude","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"R88-14-20210206","first-page":"119","article-title":"Fatal multiorgan failure after suicidal overdose with MDMA, \u2018ecstasy\u2019: case report and review of the literature","volume":"18","author":"Walubo","year":"1999","journal-title":"Hum Exp Toxicol"},{"key":"R89-14-20210206","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/15563650701639071","article-title":"Unusual complications of heroin abuse: transverse myelitis, rhabdomyolysis, compartment syndrome, and ARF","volume":"46","author":"Sahni","year":"2008","journal-title":"Clin Toxicol (Phila)"},{"key":"R90-14-20210206","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1093\/ndt\/13.10.2654","article-title":"Necrotizing renal vasculopathy resulting in chronic renal failure after ingestion of methamphetamine and 3,4-methylenedioxymethamphetamine (\u2018ecstasy\u2019)","volume":"13","author":"Bingham","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"R91-14-20210206","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.5858\/2007-131-1817-TMICAM","article-title":"Thrombotic microangiopathy in cocaine abuse-associated malignant hypertension: report of 2 cases with review of the literature","volume":"131","author":"Gu","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"R92-14-20210206","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0002-9629(15)41845-2","article-title":"Case reports: cocaine-associated accelerated hypertension and renal failure","volume":"312","author":"Thakur","year":"1996","journal-title":"Am J Med Sci"},{"key":"R93-14-20210206","doi-asserted-by":"crossref","first-page":"234","DOI":"10.5414\/CNP72234","article-title":"Renal infarction after cocaine abuse: a case report and review","volume":"72","author":"Hoefsloot","year":"2009","journal-title":"Clin Nephrol"},{"key":"R94-14-20210206","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0387-7604(00)00103-0","article-title":"Haloperidol-induced rhabdomyolysis without neuroleptic malignant syndrome in a handicapped child","volume":"22","author":"Yoshikawa","year":"2000","journal-title":"Brain Dev"},{"key":"R95-14-20210206","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jemermed.2005.08.020","article-title":"Statin-induced rhabdomyolysis","volume":"31","author":"Schreiber","year":"2006","journal-title":"J Emerg Med"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0b013e328343cd16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T10:47:31Z","timestamp":1740912451000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008480-201104000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":95,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0b013e328343cd16","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}